Journal of Immunology Research / 2017 / Article / Tab 6 / Review Article
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review Table 6 Overview of polymorphisms in genes encoding antigen processing machinery components and association with cervical neoplasia risk/survival.
Gene Cohort Cases Population Distribution Risk (OR, 95% CI); Reference ERAP1 ERAP1 -127 (c.+380G>C rs26653)Cervical cancer 127 Dutch Alleles C: 1.652 (1.106 –2.467); 12.4% [41 ] 98 Javanese Alleles C: 0.656 (0.437 –0.985) [42 ] ERAP1 -730 (c.+2188C>G; rs27044)Cervical cancer 127 Dutch Alleles G: 1.685 (1.136 –2.500); 13.6% [41 ] 98 Javanese Alleles G: 0.644 (0.431 –0.962) [42 ] ERAP1 -528 (c.+1583C>T; rs30187)Cervical cancer 98 Javanese Alleles T: 0.643 (0.429 –0.964) [42 ] LMP7 LMP7 -145 (c.145C>A; rs2071543)Cervical cancer 127 Dutch Alleles A: 0.565 (0.346 –0.920) [41 ] TAP1 TAP1 -333 (c.+1177A>G; rs4148880)CIN III 114 American Genotypes AG/GG: 0.28 (0.10 –0.80) [43 ] TAP1 TAP1 -637 (A>G; rs1135216)CIN III 114 American Genotypes AG/GG: 0.27 (0.1 –0.7) [43 ] TAP2 TAP2 -651 (c.+1951C>A; rs4148876)Cervical cancer 127 Dutch Alleles A: 0.481 (0.246 –0.942) [41 ] 103 Balinese Alleles A: 3.837 (2.379 –6.189); 47.2% [42 ] TAP2 TAP2 -379 (c.1135G>A; rs4148873)CIN 616 Caucasian Alleles A: 0.5 (0.4 –0.8) [44 ] Various APM gene combinations ERAP1 -127(G>C)/ERAP1 -730(C>G)/TAP2 -651(C>A)/LMP7 -145(C>A)Cervical cancer 127 Dutch Haplotypes C/G/C/C: 3.024 (1.656 –5.519); 11.6% [41 ] ERAP1 -575(C>T)/TAP2 -379(G>A)/TAP2 -651(C>A)Cervical cancer 98 Javanese Haplotypes T/C/G: 3.36 (0.98 –11.56); 3.9% [42 ] ERAP1 -56(G>A)/ERAP1 -127 (G>C)Cervical cancer survival 75 Dutch Haplotypes G/C heterozygotes: 0.219 (0.065 –0.731 [45 ]
n : number of cases; OR: odds ratio; 95% CI: 95% confidence interval; CIN: cervical intraepithelial neoplasia; PAF: population attributable fraction. variation and dbSNP reference number. relative to major allele or major allele homozygotes. listed if OR > 1.00. associations listed in bold. ratio listed for survival analysis.